SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABMD - Replacement Heart System
ABMD 381.020.0%Jan 3 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: High-Tech East who wrote (20)8/24/2000 8:42:27 PM
From: Lynn  Read Replies (1) of 147
 
Dear Ken: If you have not talked to your wife yet, be sure to also tell her ABMD is having a 2:1 split.

Monday August 14, 8:56 am Eastern Time

Press Release

ABIOMED, Inc. Announces Two-for-One
Stock Split

DANVERS, Mass.--(BW HealthWire)--Aug. 14, 2000--ABIOMED, Inc. (pronounced
``AB-EE-O-MED''), (NASDAQ:ABMD - news) announced today that its Board of Directors has
approved a two-for-one split of the Company's outstanding shares of common stock to be effected in
the form of a stock dividend.

Each shareholder of record at the close of business on August 25, 2000 will be entitled to receive
one additional share of common stock for each share of common stock held on that date. The stock
dividend resulting from the stock split is expected to be distributed by the Company's transfer agent
on or about September 30, 2000. ABIOMED's common stock will trade on a split-adjusted basis on
or about October 1, 2000. As of August 14, 2000, the Company had approximately 10,245,000
common shares outstanding. Upon completion of the stock split, the number will increase to
approximately 20,490,000 common shares outstanding. Shares held for issuance in connection with
all stock option plans and rights plans of the Company will also be split on a two-for-one basis in
accordance with the provisions of each such plan.

Based in Danvers, Massachusetts, ABIOMED, Inc. develops, manufactures and markets innovative
cardiovascular products and is a leader in the research and development of advanced heart assist
and heart replacement systems. The Company's BVS® is the most widely used FDA-approved
advanced cardiac assist device for patients with reversible heart failure. The Company's
AbioCor(TM) Implantable Replacement Heart is in an advanced stage of development and is
intended to extend the lives of patients with irreversible end-stage heart failure.

biz.yahoo.com

Regards,

Lynn

P.S. Do you think the recent price action has been related to this split announcement?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext